ADAC to ship Skylight sometime after October
ADAC Laboratories has a first customer for its recently approved Skylight nuclear medicine camera: Cedars-Sinai Medical Center in Los Angeles.Cedars-Sinai placed an order for the $1 million imaging device, along with a C-PET positron emission
ADAC Laboratories has a first customer for its recently approved Skylight nuclear medicine camera: Cedars-Sinai Medical Center in Los Angeles.
Cedars-Sinai placed an order for the $1 million imaging device, along with a C-PET positron emission tomography system and three Forte gamma cameras, at the end of May. ADAC will begin delivering systems sometime in the company's fiscal year 2001, which begins in October.
The cameras will be installed in the hospital's S. Mark Taper Imaging Department. Nonprofit Cedars-Sinai's imaging department performs more than 264,000 examinations annually.
ADAC claims the gantry-free Skylight system is revolutionary in design. Its architecture allows gamma detectors to be mounted in a room structure, which removes limitations associated with the floor-based mechanical gantries of other nuclear medicine systems. ADAC received FDA approval to market the Skylight in May (SCAN 5/10/00).
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
